Works by Kim, Si-Young


Results: 31
    1
    2
    3
    4
    5
    6

    Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.

    Published in:
    Gastric Cancer, 2015, v. 18, n. 4, p. 824, doi. 10.1007/s10120-014-0420-9
    By:
    • Satoh, Taroh;
    • Lee, Kyung;
    • Rha, Sun;
    • Sasaki, Yasutsuna;
    • Park, Se;
    • Komatsu, Yoshito;
    • Yasui, Hirofumi;
    • Kim, Tae-You;
    • Yamaguchi, Kensei;
    • Fuse, Nozomu;
    • Yamada, Yasuhide;
    • Ura, Takashi;
    • Kim, Si-Young;
    • Munakata, Masaki;
    • Saitoh, Soh;
    • Nishio, Kazuto;
    • Morita, Satoshi;
    • Yamamoto, Eriko;
    • Zhang, Qingwei;
    • Kim, Jung-mi
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.

    Published in:
    Oncologist, 2015, v. 20, n. 12, p. 1440, doi. 10.1634/theoncologist.2015-0128
    By:
    • Kim, Hyo Jung;
    • Shin, Sang Won;
    • Song, Eun‐Kee;
    • Lee, Na‐Ri;
    • Kim, Jun Suk;
    • Ahn, Jin Seok;
    • Yun, Hwan‐Jung;
    • Cho, Yo‐Han;
    • Park, Keon Uk;
    • Kim, Si‐Young;
    • Jang, Joung Soon;
    • Kim, Sang‐We;
    • Lee, Hyun Woo;
    • Lee, Se Ryeon;
    • Kim, Yang Soo;
    • Lee, Soon Nam;
    • Ko, Yoon Ho;
    • Kim, Hwa Jung;
    • Kang, Jin‐Hyoung
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    The association of self-leadership, health behaviors, and posttraumatic growth with health-related quality of life in patients with cancer.

    Published in:
    Psycho-Oncology, 2014, v. 23, n. 12, p. 1423, doi. 10.1002/pon.3582
    By:
    • Yun, Young Ho;
    • Sim, Jin Ah;
    • Jung, Ju Youn;
    • Noh, Dong‐Young;
    • Lee, Eun Sook;
    • Kim, Young Woo;
    • Oh, Jae Hwan;
    • Ro, Jung Sil;
    • Park, Sang Yoon;
    • Park, Sang Jae;
    • Cho, Kwan Ho;
    • Chang, Yoon Jung;
    • Bae, Yeon Min;
    • Kim, Si Young;
    • Jung, Kyung Hae;
    • Zo, Zae Ill;
    • Lim, Jae‐Young;
    • Lee, Soon Nam
    Publication type:
    Article
    24
    25
    26
    27

    A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.

    Published in:
    2016
    By:
    • Oh, Do-Youn;
    • Im, Seock-Ah;
    • Lee, Ki;
    • Han, Hye;
    • Park, Jae;
    • Choi, Young;
    • Kim, Hee-Jun;
    • Jung, Kyung;
    • Kim, Si-Young;
    • Kim, Ji-Yeon;
    • Lee, Moon;
    • Lim, Joo;
    • Park, Keon;
    • Park, In;
    • Cho, Eun;
    • Yoon, So;
    • Kim, Jee;
    • Choi, In;
    • Lee, Ki Hyeong;
    • Lee, Moon Hee
    Publication type:
    journal article
    28
    29
    30
    31